https://scholars.lib.ntu.edu.tw/entities/publication/c74835d7-6f1c-407e-8bae-323b77c73736
A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon...
randomized controlled trial
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1109866/full
Frontiers | An alternative dosing strategy for ropeginterferon alfa-2b may help improve outcomes in...
Ropeginterferon alfa-2b is a novel, long-acting mono-pegylated proline-IFN-alpha-2b approved for treatment of polycythemia vera in adults, regardless of thro...
https://adisinsight.springer.com/trials/700392453?error=cookies_not_supported&code=dee5056a-ebd1-4d82-b91e-dfb6c2497c0c
A Phase 1b Study of Safety, Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib...
The purpose of this clinical trial is to learn if the study drug ropeginterferon alfa- 2b added to, standard of care, ruxolitinib is safe and effective in
https://medlineplus.gov/druginfo/meds/a622019.html
Ropeginterferon alfa-2b: MedlinePlus Drug Information
Ropeginterferon alfa-2b: learn about side effects, dosage, special precautions, and more on MedlinePlus
alfamedlineplusdruginformation